Characterization of [Nphe1]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist

British Journal of Pharmacology

Volumn 129, Issue 6, 2000, Pages 1183-1193

  Calo', Girolamo ^a   Guerrini, Remo ^a   Bigoni, Raffaella ^a   Rizzi, Anna ^a   Marzola, Giuliano ^a   Okawa, Hirobumi ^b   Bianchi, Clementina ^a   Lambert, David G ^b   Salvadori, Severo ^a   Regoli, Domenico ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Analgesia; Isolated tissues; Morphine; Mouse tail withdrawal assay; Native and recombinant receptors; Nociceptin; Nociceptin receptor antagonist

Indexed keywords

CYCLIC AMP; MORPHINE; NALOXONE; NOCICEPTIN; NOCICEPTIN RECEPTOR; PHENYL NOCICEPTIN; RECEPTOR BLOCKING AGENT; RECOMBINANT RECEPTOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHO CELL; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; ELECTROSTIMULATION; GUINEA PIG; MALE; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0034101842     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703169     Document Type: Article

References (48)

1. BIGONI, R., GIULIANI, S., CALO, G., RIZZI, A., GUERRINI, R., SALVADORI, S., REGOLI, D. & MAGGI. C.A. (1999). Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. N S Arch. Pharmacol., 359, 160-167.
2. BUTOUR, J.L., MOISAND, C., MOLLEREAU, C. & MEUNIER, J.C. (1998). [Phe1psi(CH2-NH)Gly2]nociceptin-(1-13)NH2 is an agonist of the nociceptin (ORL1) receptor. Eur. J. Pharmacol., 349, R5-R6.
3. CALO, G., RIZZI, A., MARZOLA, G., GUERRINI, R., SALVADORI, S., BEANI, L., REGOLI, D. & BIANCHI, C. (1998). Pharmacological characterization of the nociceptin receptor binding hyperalgesia in the mouse tail withdrawal assay. Br. J. Pharmacol., 125, 373-378.
4. CIVELLI, O., NOTHACKER, H.P. & REINSCHEID, R. (1998). Reverse physiology: discovery of the novel neuropeptide, orphanin FQ/nociceptin. Crit. Rev. Neurobiol., 12, 163-176.
5. CONNOR, M., VAUGHAN, C.W., CHIENG, B. & CHRISTIE, M.J. (1996a). Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol., 119, 1614-1618.
6. CONNOR, M., YEO, A. & HENDERSON, G. (1996b). The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line. Br. J. Pharmacol., 118, 205-207.
7. DEVINE, D.P., REINSCHEID, R.K., MONSMA, F.J., CIVELLI, O. & AKIL, H. (1996). The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res., 727, 225-229.
8. DOOLEY, C.T., SPAETH, C.G., BERZETEI-GURSKE, I.P., CRAYMER, K., ADAPA, I.D., BRANDT, S.R., HOUGHTEN, R.A. & TOLL, L. (1997). Binding and in vitro activities of peptides with high affinity for the Nociceptin/Orphanin FQ receptor, ORL1. J. Pharmacol. Exp. Ther., 283, 735-741.
9. GIULIANI, S. & MAGGI, C.A. (1996). Inhibition of tachykinin release from peripheral endings of sensory nerves by nociceptin, a novel opioid peptide. Br. J. Pharmacol., 118, 1567-1569.
10. GUERRINI, R., CALO, G., BIGONI, R., RIZZI, A., VARANI, K., TOTH, G., GESSI, S., BOREA, P.A., SALVADORI, S. & REGOLI, D. (1999). Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor. Regul. Peptides, 80, 124.
11. GUERRINI, R., CALO, G., RIZZI, A., BIANCHI, C., LAZARUS, L.H., SALVADORI, S., TEMUSSI, P.A. & REGOLI, D. (1997). Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem., 40, 1789-1793.
12. GUERRINI, R., CALO, G., RIZZI, A., BIGONI, R., BIANCHI, C., SALVADORI, S. & REGOLI, D. (1998). A new selective antagonist of the nociceptin receptor. Br. J. Pharmacol., 123, 163-165.
13. HAMON, M. (1998). The new approach to opioid receptors. N.S. Arch. Pharmacol., 358 (Suppl 2), SA 5.3.
14. 2 on nociceptin receptor mediated inhibition of cAMP formation in Chinese ovary cells stably expressing the recombinant human nociceptin receptor. Neurosci. Lett., 278, 109-112.
15. HAYES, A.G., BIRCH, P.P. & CAVICCHINI, E. (1998). Evidence that the kappa agonist U50488H has non-opioid actions. J. Pharm. Pharmacol., 40, 718-720.
16. HIRST, R.A., HIROTA, K., GRANDY, D.K. & LAMBERT, D.G. (1997). Coupling of the cloned rat k-opioid receptor to adenylyl cyclase is dependent on receptor expression. Neurosci. Lett., 232, 119-122.
17. HIRST, R.A., SMART, D., DEVI, L.A. & LAMBERT, D.G. (1998). Effects of C-terminal truncation of the recombinant delta opioid receptor on phospholipase C and anenylyl cyclase coupling. J. Neurochem., 70, 2273-2278.
18. HJORTH, S.A., THIRSTRUP, K., GRANDY, D.K. & SCHWARTZ, T.W. (1995). Analysis of selective binding epitopes for the kappa opioid receptor antagonist norbinaltorphimine. Mol. Pharmacol., 47, 1089-1094.
19. HUNTER, J.C., LEIGHTON, G.E., MEECHAM, K.G., BOYLE, S.J., HORWELL, D.C., REES, D.C. & HUGHES, J. (1990). CI-977, a novel and selective agonist for the kappa-opioid receptor. Br. J. Pharmacol., 101, 183-189.
20. JENKINSON, D.H., BARNARD, E.A., HOYER, D., HUMPHREY, P.P.A., LEFF, P. & SHANKLEY, N.P. (1995). International Union of Pharmacology Committee on receptor nomenclature and drug classification X1 Recommendation on terms and symbols in quantitative pharmacology. Pharmacol. Rev., 47, 255-266.
21. KIEFFER, B.L. (1999). Opioids: first lessons from knockout mice. Trends Pharmacol. Sci., 20, 19-26.
22. KOBAYASHI, T., IKEDA, K., TOGASHI, S., ITOH, N. & KUMANISHI, T. (1997). Effects of sigma ligands on the nociceptin/orphanin FQ receptor co-expressed with the G-protein-activated K+ channel in Xenopus oocytes. Br. J. Pharmacol., 120, 986-987.
23. KOSTER, A., MONTKOWSKI, A., SCHULZ, S., STUBE, E.M., KNAUDT, K., JENCK, F., MOREAU, J.L., NOTHACKER, H.P., CIVELLI, O. & REINSCHEID, R.K. (1999). Targeted disruption of the orphanin FQ/nociceptin gene increases stress susceptibility and impairs stress adaptation in mice. Proc. Natl. Acad. Sci. U.S.A., 96, 10444-10449.
24. LEIGHTON, G.E, RODRIGUEZ, R.E., HILL, R.G & HUGHES, J. (1988). kappa-Opioid agonists produce antinociception after i.v. and i.e.v. but not intrathecal administration in the rat. Br. J. Pharmacol., 93, 553-560.
25. LEVENTHAL, L., MATHIS, J.P., ROSSI, G.C., PASTERNAK, G.W. & BODNAR, R.J. (1998). Orphan opioid receptor antisense probes block orphanin FQ-induced hyperphagia. Eur. J. Pharmacol., 349, R1-R3.
26. MADEDDU, P., SALIS, M.B., MILIA, A.F., EMANUELI, C., GUERRINI, R., REGOLI, D. & CALO, G. (1999). Cardiovascular effects of nociceptin in unanesthetized mice. Hypertension, 33, 914-919.
27. MANABE, T., NODA, Y., MAMIYA, T., KATAGIRI, H., HOUTANI, T., NISHI, M., NODA, T., TAKAHASHI, T., SUGIMOTO, T., NABESHIMA, T. & TAKESHIMA, H. (1998). Facilitation of long-term potentiation and memory in mice lacking nociccptin receptors. Nature, 394, 577-581.
28. MATTHES, H.W., MALDONADO, R. SIMONIN, F., VALVERDE, O., SLOWE, S., KITCHEN, I., BEFORT, K., DIERICH, A., LEMEUR, M., DOLLE, P., TZAVARA, E., HANOUNE, J., ROQUES, B.P. & KIEFFER, B.L. (1996). Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene [sec comments]. Nature, 383, 819-823.
29. MENZIES, J.R.W., GLEN, T., DAVIES, M.R.P., PATERSON, S.J. & CORBETT, A.D. (1999). In vitro effects of nociceptin and [Phe1psi(Ch2-NH)Gly2]nociceptin(1-13)NH2 in the mouse and rat colon and the mouse vas deferens. Eur. J. Pharmacol., 385, 217-223.
30. MEUNIER, J.C., MOLLEREAU, C., TOLL, L., SUAUDEAU, C., MOISAND, C., ALVINERIE, P., BUTOUR, J.L., GUILLEMOT, J.C., FERRARA, P., MONSERRAT, B., MAZARGUIL, H., VASSART, G., PARMENTIER, M. & COSTENTIN, J. (1985). Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature, 377, 532-535.
31. MEUNIER, J.C. (1997). Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol., 340, 1-15.
32. MOGIL, J.S., GRISEL, J.E., REINSCHEID, R.K., CIVELLI, O., BELKNAP, J.K & GRANDY, D.K. (1996). Orphanin FQ is a functional anti-opioid peptide. Neuroscience, 75, 333-337.
33. NICHOLSON, J.R., PATERSON, S.J., MENZIES, J.R., CORBETT, A.D. & MCKNIGHT, AT. (1998). Pharmacological studies on the 'orphan' opioid receptor in central and peripheral sites. Can. J. Physiol. Pharmacol., 76, 304-313.
34. NISHI, M., HOUTANI, T., NODA, Y., MAMIYA, T., SATO, K., DOI, T., KUNO, J., TAKESHIMA, H., NUKADA, T., NABESHIMA, T., YAMASHITA, T., NODA, T. & SUGIMOTO, T. (1997). Unrestrained nociceptive response and disregulation of hearing ability in mice lacking the nociceptin/orphaninFQ receptor. EMBO J., 16, 1858-1864.
35. NODA, Y., MAMIYA, T., NABESHIMA, T., NISHI, M., HIGASHIOKA, M. & TAKESHIMA, H. (1998). Loss of antinociception induced by naloxone benzoylhydrazone in nociceptin receptor-knockout mice. J. Biol. Chem., 273, 18047-18051.
36. OKAWA, H., HIRST, R.A., SMART, D., McKNIGHT, A.T. & LAMBERT, D.G. (1998). Studies on the coupling of recombinant ORL1 receptors to adenylyl cyclase. Br. J. Pharmacol., 123, 218P.
37. OKAWA, H., NICOL., B., BIGONI, R., HIRST, R.A., CALO, G., GUERRINI, R., ROWBOTHAM, D.J., SMART, D., MCKNIGHT, A.T. & LAMBERT, D.G. (1999). Comparison of the effects of the Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors. Br. J. Pharmacol., 127, 123-130.
38. PAUL, D., LEVISON, J.A., HOWARD, D.H., PICK, C.G., HAHN, E.F. & PASTERNAK, G.W. (1990). Naloxone benzoylhydrazone (NaIBzoH) analgesia. J. Pharmacol. Exp. Ther., 255, 769-774.
39. POLIDORI, C., CALO, G., CICCOCIOPPO, R., GUERRINI, R., REGOLI, D. & MASSI, M. (2000). Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist. Psychopharmacology, in press.
40. REINSCHEID, R.K., NOTHACKER, H.P., BOURSON, A., ARDATI, A., HENNINGSEN, R.A., BUNZOW, J.R., GRANDY, D.K., LANGEN, H., MONSMA, F.J. & CIVELLI, O. (1995). Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science, 270, 792-794.
41. 2 antagonizes nociceptin effects in the mouse colon. Eur. J. Pharmacol., 385, R3-R5.
42. SCHLICKER, E., WERTHWEIN, S., KATHMANN, M. & BAUER, U. (1998). Nociceptin inhibits noradrenaline release in the mouse brain cortex via presynaptic ORLI receptors. N.S. Arch. Pharmacol., 358, 418-422.
43. SMART, D., HIRST, R.A., HIROTA, K., GRANDY, D.K. & LAMBERT, D.G. (1997). The effects of recombinant rat mu opioid receptor activation in CHO cells on phospholipase C, [Ca2+ ]i and adenylyl cyclase. Br. J. Pharmacol., 120, 1165-1171.
44. TIAN, J.H., XU, W., ZHANG, W., FANG, Y., GRISEL, J.E., MOGIL, J.S., GRANDY, D.K. & HAN, J.S. (1997). Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia. Neuroreport, 8, 497-500.
45. TIAN, J.H., ZHANG, W., FANG, Y., XU, W., GRANDY, D.K. & HAN, J.S. (1998). Endogenous orphanin FQ: evidence for a role in the modulation of electroacupuncture analgesia and the development of tolerance to analgesia produced by morphine and electroacupuncture. Br. J. Pharmacol., 124, 21-26.
46. UEDA, H., YAMAGUCHI, T., TOKUYAMA, S., INOUE, M., NISHI, M. & TAKESHIMA, H. (1997). Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene. Neurosci. Lett., 237, 136-138.
47. XU, I.S., WIESENFELD-HALLIN, Z. & XU, X.J. (1998). [Phe1psi(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cord. Neurosci. Lett., 249, 127-130.
48. ZHU, C.B., CAO, X.D., XU, S.F. & WU, G.C. (1997). Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats. Neurosci. Lett., 235, 37-40.